Used as a chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its oxazole core and stereospecific center enhance binding selectivity and metabolic stability in drug candidates. Commonly employed in oncology-related research for optimizing small molecule therapeutics. Also utilized in asymmetric synthesis to introduce structural complexity in medicinal chemistry campaigns.